Jonathan H. Kaufman

Insider Reports History

Identity Names, identifiers, and filing context for this profile. 1 identity field
Reporting-owner location
Pittsburgh, PA
SEC source record Original filing metadata and source links for verification. 1 source field
Latest reporting-owner signature
/s/ Jonathan H. Kaufman
Source: Latest parsed Forms 3/4/5 signature
Source evidence Original filing metadata and source links for verification. 1 source field
Transaction source note
Rows are grouped by transaction date from the original SEC filing. Open the aggregated insider activity page to review issuer-level activity across dates.

Reported holdings for Jonathan H. Kaufman

Form 4 holding President, Chief Executive Officer, Secretary, Treasurer, and Chairman of the Board of Directors, Director, 10%+ Owner

LIPELLA PHARMACEUTICALS INC.

Security class
Common Stock
Shares / value
898,849
Estimated value
$682,226
Report date
14 May 2024
Price
$0.7590
Ownership
Direct
Form 4 holding President, Chief Executive Officer, Secretary, Treasurer, and Chairman of the Board of Directors, Director, 10%+ Owner

LIPELLA PHARMACEUTICALS INC.

Security class
Common Stock Purchase Warrants
Shares / value
0
Estimated value
Report date
03 Apr 2025
Price
Ownership
By Self as proxy and power of attorney for Spartan and an Affiliate
Underlying class
Common Stock
Underlying amount
Form 4 holding President, Chief Executive Officer, Secretary, Treasurer, and Chairman of the Board of Directors, Director, 10%+ Owner

LIPELLA PHARMACEUTICALS INC.

Security class
Series C Voting Convertible Preferred Stock
Shares / value
0
Estimated value
Report date
03 Apr 2025
Price
Ownership
By Self as proxy and power of attorney for Spartan and an Affiliate (each as defined below)
Underlying class
Common Stock
Underlying amount

Insider Reports Filed by Jonathan H. Kaufman

4 LIPO

LIPELLA PHARMACEUTICALS INC.

Report period
03 Apr 2025
Transactions
4
Transaction value
$0
Accepted by SEC
07 Apr 2025, 19:16
Role
President, Chief Executive Officer, Secretary, Treasurer, and Chairman of the Board of Directors, Director, 10%+ Owner
Next action
Open filing details
4 LIPO

LIPELLA PHARMACEUTICALS INC.

Report period
15 Jan 2025
Transactions
3
Transaction value
$0
Accepted by SEC
17 Jan 2025, 20:13
Role
President, Chief Executive Officer, Secretary, Treasurer, and Chairman of the Board of Directors., Director, 10%+ Owner
Next action
Open filing details
4 LIPO

LIPELLA PHARMACEUTICALS INC.

Report period
14 May 2024
Transactions
1
Transaction value
+$7,590
Accepted by SEC
15 May 2024, 16:39
Role
President, Chief Executive Officer, Secretary, Treasurer, and Chairman of the Board of Directors, Director, 10%+ Owner
Next action
Open filing details
4 LIPO

LIPELLA PHARMACEUTICALS INC.

Report period
15 Mar 2024
Transactions
3
Transaction value
+$45,452
Accepted by SEC
19 Mar 2024, 18:21
Role
President, Chief Executive Officer, Secretary, Treasurer, and Chairman of the Board of Directors, Director, 10%+ Owner
Next action
Open filing details
4 LIPO

LIPELLA PHARMACEUTICALS INC.

Report period
13 Mar 2024
Transactions
1
Transaction value
+$100,000
Accepted by SEC
15 Mar 2024, 12:20
Role
President, Chief Executive Officer, Secretary, Treasurer, and Chairman of the Board of Directors, Director, 10%+ Owner
Next action
Open filing details
4 LIPO

LIPELLA PHARMACEUTICALS INC

Report period
16 Jun 2023
Transactions
1
Transaction value
$0
Accepted by SEC
21 Jun 2023, 16:57
Role
President, Chief Executive Officer, Secretary, Treasurer, and Chairman of the Board of Directors, Director, 10%+ Owner
Next action
Open filing details
3 LIPO

LIPELLA PHARMACEUTICALS INC

Report period
19 Dec 2022
Transactions
0
Transaction value
$0
Accepted by SEC
20 Dec 2022, 20:48
Role
President, Chief Executive Officer, Secretary, Treasurer, and Chairman of the Board of Directors, Director, 10%+ Owner
Next action
Open filing details
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .